Patient characteristics driving clinical utility in psychiatric pharmacogenetics: a reanalysis from the AB-GEN multicentric trial

Clinical utility of commercial multi-gene pharmacogenetic tests in depression is starting to be studied with some promising results on efficacy and tolerability. Among the next steps is the definition of the patient profile that is most likely to benefit from testing. Here we present a reanalysis of...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Neural Transmission 2019-01, Vol.126 (1), p.95-99
Main Authors: Menchón, J. M., Espadaler, J., Tuson, M., Saiz-Ruiz, J., Bobes, J., Vieta, E., Álvarez, E., Pérez, V.
Format: Article
Language:English
Subjects:
Medicine
Medicine & Public Health
NCT
NCT02529462
Neurology
Neurosciences
Psychiatry
Psychiatry and Preclinical Psychiatric Studies - Original Article
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c344t-cd58f01da25c47ae975c8f1f573992dc6db6a0378dbb9f83eff5f1343b6685483
cites cdi_FETCH-LOGICAL-c344t-cd58f01da25c47ae975c8f1f573992dc6db6a0378dbb9f83eff5f1343b6685483
container_end_page 99
container_issue 1
container_start_page 95
container_title Journal of Neural Transmission
container_volume 126
creator Menchón, J. M.
Espadaler, J.
Tuson, M.
Saiz-Ruiz, J.
Bobes, J.
Vieta, E.
Álvarez, E.
Pérez, V.
description Clinical utility of commercial multi-gene pharmacogenetic tests in depression is starting to be studied with some promising results on efficacy and tolerability. Among the next steps is the definition of the patient profile that is most likely to benefit from testing. Here we present a reanalysis of data from the AB-GEN randomized clinical trial showing that clinical utility of pharmacogenetic testing can be markedly influenced by patient characteristics such as age, baseline severity and duration of current depressive episode. Trial registration ClinicalTrials.gov NCT02529462.
doi_str_mv 10.1007/s00702-018-1879-z
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1007_s00702_018_1879_z</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2035241979</sourcerecordid><originalsourceid>FETCH-LOGICAL-c344t-cd58f01da25c47ae975c8f1f573992dc6db6a0378dbb9f83eff5f1343b6685483</originalsourceid><addsrcrecordid>eNp9kLFuHCEURZGVKLux8wFuLMo0xDDAAO6cleNYspIUdo0YBnZZMTNrYCytu_y5Wa2dMs17xTv3PukAcE7wN4KxuMx14AZhIhGRQqGXE7AkjHJEWEs_gCWmGCPFW7YAn3PeYowJEfITWDRKNFK2ZAn-_jEluLFAuzHJ2OJSyCXYDPsUnsO4hjaGMVgT4VxCDGUPwwh3eW83wZQULNzV3GDstHajOwSvoIHJmdHEfQ4Z-jQNsGwcvP6Obm9-wWGOlaoPD9k6TDwDH72J2X1526fg8cfNw-onuv99e7e6vkeWMlaQ7bn0mPSm4ZYJ45TgVnriuaBKNb1t-641mArZd53ykjrvuSeU0a5tJWeSnoKvx95dmp5ml4seQrYuRjO6ac66wZQ3jCihKkqOqE1Tzsl5vUthMGmvCdYH8_poXlfz-mBev9TMxVv93A2u_5d4V12B5gjkehrXLuntNKfqKf-n9RVEa5H-</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2035241979</pqid></control><display><type>article</type><title>Patient characteristics driving clinical utility in psychiatric pharmacogenetics: a reanalysis from the AB-GEN multicentric trial</title><source>Springer Nature</source><creator>Menchón, J. M. ; Espadaler, J. ; Tuson, M. ; Saiz-Ruiz, J. ; Bobes, J. ; Vieta, E. ; Álvarez, E. ; Pérez, V.</creator><creatorcontrib>Menchón, J. M. ; Espadaler, J. ; Tuson, M. ; Saiz-Ruiz, J. ; Bobes, J. ; Vieta, E. ; Álvarez, E. ; Pérez, V.</creatorcontrib><description>Clinical utility of commercial multi-gene pharmacogenetic tests in depression is starting to be studied with some promising results on efficacy and tolerability. Among the next steps is the definition of the patient profile that is most likely to benefit from testing. Here we present a reanalysis of data from the AB-GEN randomized clinical trial showing that clinical utility of pharmacogenetic testing can be markedly influenced by patient characteristics such as age, baseline severity and duration of current depressive episode. Trial registration ClinicalTrials.gov NCT02529462.</description><identifier>ISSN: 0300-9564</identifier><identifier>EISSN: 1435-1463</identifier><identifier>DOI: 10.1007/s00702-018-1879-z</identifier><identifier>PMID: 29728861</identifier><language>eng</language><publisher>Vienna: Springer Vienna</publisher><subject>Medicine ; Medicine &amp; Public Health ; NCT ; NCT02529462 ; Neurology ; Neurosciences ; Psychiatry ; Psychiatry and Preclinical Psychiatric Studies - Original Article</subject><ispartof>Journal of Neural Transmission, 2019-01, Vol.126 (1), p.95-99</ispartof><rights>Springer-Verlag GmbH Austria, part of Springer Nature 2018</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c344t-cd58f01da25c47ae975c8f1f573992dc6db6a0378dbb9f83eff5f1343b6685483</citedby><cites>FETCH-LOGICAL-c344t-cd58f01da25c47ae975c8f1f573992dc6db6a0378dbb9f83eff5f1343b6685483</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29728861$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Menchón, J. M.</creatorcontrib><creatorcontrib>Espadaler, J.</creatorcontrib><creatorcontrib>Tuson, M.</creatorcontrib><creatorcontrib>Saiz-Ruiz, J.</creatorcontrib><creatorcontrib>Bobes, J.</creatorcontrib><creatorcontrib>Vieta, E.</creatorcontrib><creatorcontrib>Álvarez, E.</creatorcontrib><creatorcontrib>Pérez, V.</creatorcontrib><title>Patient characteristics driving clinical utility in psychiatric pharmacogenetics: a reanalysis from the AB-GEN multicentric trial</title><title>Journal of Neural Transmission</title><addtitle>J Neural Transm</addtitle><addtitle>J Neural Transm (Vienna)</addtitle><description>Clinical utility of commercial multi-gene pharmacogenetic tests in depression is starting to be studied with some promising results on efficacy and tolerability. Among the next steps is the definition of the patient profile that is most likely to benefit from testing. Here we present a reanalysis of data from the AB-GEN randomized clinical trial showing that clinical utility of pharmacogenetic testing can be markedly influenced by patient characteristics such as age, baseline severity and duration of current depressive episode. Trial registration ClinicalTrials.gov NCT02529462.</description><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>NCT</subject><subject>NCT02529462</subject><subject>Neurology</subject><subject>Neurosciences</subject><subject>Psychiatry</subject><subject>Psychiatry and Preclinical Psychiatric Studies - Original Article</subject><issn>0300-9564</issn><issn>1435-1463</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kLFuHCEURZGVKLux8wFuLMo0xDDAAO6cleNYspIUdo0YBnZZMTNrYCytu_y5Wa2dMs17xTv3PukAcE7wN4KxuMx14AZhIhGRQqGXE7AkjHJEWEs_gCWmGCPFW7YAn3PeYowJEfITWDRKNFK2ZAn-_jEluLFAuzHJ2OJSyCXYDPsUnsO4hjaGMVgT4VxCDGUPwwh3eW83wZQULNzV3GDstHajOwSvoIHJmdHEfQ4Z-jQNsGwcvP6Obm9-wWGOlaoPD9k6TDwDH72J2X1526fg8cfNw-onuv99e7e6vkeWMlaQ7bn0mPSm4ZYJ45TgVnriuaBKNb1t-641mArZd53ykjrvuSeU0a5tJWeSnoKvx95dmp5ml4seQrYuRjO6ac66wZQ3jCihKkqOqE1Tzsl5vUthMGmvCdYH8_poXlfz-mBev9TMxVv93A2u_5d4V12B5gjkehrXLuntNKfqKf-n9RVEa5H-</recordid><startdate>20190121</startdate><enddate>20190121</enddate><creator>Menchón, J. M.</creator><creator>Espadaler, J.</creator><creator>Tuson, M.</creator><creator>Saiz-Ruiz, J.</creator><creator>Bobes, J.</creator><creator>Vieta, E.</creator><creator>Álvarez, E.</creator><creator>Pérez, V.</creator><general>Springer Vienna</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20190121</creationdate><title>Patient characteristics driving clinical utility in psychiatric pharmacogenetics: a reanalysis from the AB-GEN multicentric trial</title><author>Menchón, J. M. ; Espadaler, J. ; Tuson, M. ; Saiz-Ruiz, J. ; Bobes, J. ; Vieta, E. ; Álvarez, E. ; Pérez, V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c344t-cd58f01da25c47ae975c8f1f573992dc6db6a0378dbb9f83eff5f1343b6685483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>NCT</topic><topic>NCT02529462</topic><topic>Neurology</topic><topic>Neurosciences</topic><topic>Psychiatry</topic><topic>Psychiatry and Preclinical Psychiatric Studies - Original Article</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Menchón, J. M.</creatorcontrib><creatorcontrib>Espadaler, J.</creatorcontrib><creatorcontrib>Tuson, M.</creatorcontrib><creatorcontrib>Saiz-Ruiz, J.</creatorcontrib><creatorcontrib>Bobes, J.</creatorcontrib><creatorcontrib>Vieta, E.</creatorcontrib><creatorcontrib>Álvarez, E.</creatorcontrib><creatorcontrib>Pérez, V.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of Neural Transmission</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Menchón, J. M.</au><au>Espadaler, J.</au><au>Tuson, M.</au><au>Saiz-Ruiz, J.</au><au>Bobes, J.</au><au>Vieta, E.</au><au>Álvarez, E.</au><au>Pérez, V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Patient characteristics driving clinical utility in psychiatric pharmacogenetics: a reanalysis from the AB-GEN multicentric trial</atitle><jtitle>Journal of Neural Transmission</jtitle><stitle>J Neural Transm</stitle><addtitle>J Neural Transm (Vienna)</addtitle><date>2019-01-21</date><risdate>2019</risdate><volume>126</volume><issue>1</issue><spage>95</spage><epage>99</epage><pages>95-99</pages><issn>0300-9564</issn><eissn>1435-1463</eissn><abstract>Clinical utility of commercial multi-gene pharmacogenetic tests in depression is starting to be studied with some promising results on efficacy and tolerability. Among the next steps is the definition of the patient profile that is most likely to benefit from testing. Here we present a reanalysis of data from the AB-GEN randomized clinical trial showing that clinical utility of pharmacogenetic testing can be markedly influenced by patient characteristics such as age, baseline severity and duration of current depressive episode. Trial registration ClinicalTrials.gov NCT02529462.</abstract><cop>Vienna</cop><pub>Springer Vienna</pub><pmid>29728861</pmid><doi>10.1007/s00702-018-1879-z</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0300-9564
ispartof Journal of Neural Transmission, 2019-01, Vol.126 (1), p.95-99
issn 0300-9564
1435-1463
language eng
recordid cdi_crossref_primary_10_1007_s00702_018_1879_z
source Springer Nature
subjects Medicine
Medicine & Public Health
NCT
NCT02529462
Neurology
Neurosciences
Psychiatry
Psychiatry and Preclinical Psychiatric Studies - Original Article
title Patient characteristics driving clinical utility in psychiatric pharmacogenetics: a reanalysis from the AB-GEN multicentric trial
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T03%3A25%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Patient%20characteristics%20driving%20clinical%20utility%20in%20psychiatric%20pharmacogenetics:%20a%20reanalysis%20from%20the%20AB-GEN%20multicentric%20trial&rft.jtitle=Journal%20of%20Neural%20Transmission&rft.au=Mench%C3%B3n,%20J.%20M.&rft.date=2019-01-21&rft.volume=126&rft.issue=1&rft.spage=95&rft.epage=99&rft.pages=95-99&rft.issn=0300-9564&rft.eissn=1435-1463&rft_id=info:doi/10.1007/s00702-018-1879-z&rft_dat=%3Cproquest_cross%3E2035241979%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c344t-cd58f01da25c47ae975c8f1f573992dc6db6a0378dbb9f83eff5f1343b6685483%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2035241979&rft_id=info:pmid/29728861&rfr_iscdi=true